Hyperfine (HYPR) Total Debt (2020 - 2026)

Hyperfine's (HYPR) quarterly Total Debt came in at $13.1 million in Q1 2026, up 20404.69% on a QoQ basis from $64000.0 in Q1 2023.

Hyperfine (HYPR) Total Debt (2020 - 2026) Analysis & Trends

Hyperfine (HYPR) has 5 years of Total Debt data on file, last reported at $13.1 million in Q1 2026.

Quarterly Total Debt changed N/A year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.1 million (changed N/A YoY) and the FY2021 annual result came in at $2.0 million, up 530.89% from the prior year.
Total Debt improved to $13.1 million in Q1 2026, from $64000.0 in the prior quarter.
In the past five years, Total Debt ranged from a high of $13.1 million in Q1 2026 to a low of $61000.0 in Q3 2022.
A 3-year average of $2.7 million and a median of $81000.0 in 2022 frame the typical range for Total Debt.
The widest YoY moves for Total Debt: up 34.02% in 2023, down 34.02% in 2023.
Tracing HYPR's Total Debt over 3 years: stood at $61000.0 in 2022, then advanced by 4.92% to $64000.0 in 2023, then surged by 20404.69% to $13.1 million in 2026.
The last three Total Debt figures came in at $13.1 million (Q1 2026), $64000.0 (Q1 2023), and $61000.0 (Q3 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	32.61 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	14.94 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	27.96 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	12.62 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	10.10 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	8.68 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	1.89 Bn
10	Hyperfine	90.12 Mn	45.35 Mn	1.98 Mn	13.24 Mn

Download Data